TRIPS waiver expansion risks public health
The Biden administration and other World Trade Organization members are considering expanding the harmful and unnecessary waiver of intellectual property (IP) protections under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) beyond COVID-19 vaccines. These governments should approach this decision with a clear understanding of one of the most significant consequences of that action: compromised public health, especially in lower-income countries.
Source: The Catalyst - Category: Pharmaceuticals Authors: Megan Van Etten Tags: Intellectual Property Coronavirus TRIPS Waiver Source Type: news
More News: Coronavirus | Covid Vaccine | COVID-19 | International Medicine & Public Health | Pharmaceuticals | Vaccines